Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade serous or endometrioid ovarian cancer: A multi-national observational study
Authors
Morgan, Robert DavidClamp, Andrew R
Barnes, Bethany M
Schlecht, H.
Yarram-Smith, L.
Wallis, Y.
Morgan, S.
Valganon, M.
Hudson, E.
McKenna, S.
Sundar, S.
Nicum, S.
Brenton, J. D.
Kristeleit, R.
Banerjee, S.
McNeish, I.
Ledermann, J. A.
Taylor, Stephen S
Evans, G.
Jayson, Gordon C
Affiliation
Medical Oncology, The Christie NHS Foundation Trust, ManchesterIssue Date
2022
Metadata
Show full item recordCitation
Morgan RD, Clamp AR, Barnes B, Schlecht H, Yarram-Smith L, Wallis Y, et al. Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade serous or endometrioid ovarian cancer: A multi-national observational study. Annals of Oncology. 2022 Sep;33(7):S810-S. PubMed PMID: WOS:000866211600567.Journal
Annals of OncologyDOI
10.1016/j.annonc.2022.07.703Additional Links
https://dx.doi.org/10.1016/j.annonc.2022.07.703Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2022.07.703